The findings, published in February in The Lancet Obstetrics, Gynaecology, & Women's Health, highlight a possible new strategy for addressing weight gain after menopause, when hormonal shifts can increase the risk of obesity, cardiovascular disease and Type 2 diabetes
Can you take GLP-1 medication without diabetes
Oral semaglutide was superior to placebo, sitagliptin, and liraglutide and similar to empagliflozin, with losses up to 4.44 kg compared with 0.53.6 kg for active-comparator arms and 0.41.4 kg compared with placebo [35,36,37,38,39,40]
J Endocrinol (2011) 209(2):20310.10.1530/JOE-11-0015 10 MaXMengJJiaMBiLZhouYWangYet alExendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats
doi: 10.1039/D5FO01780G 329 Kamierczak-SiedleckaKRuszkowskiJFicMFolwarskiMMakarewiczW
GLP-1, ,